Zhitong Finance App News, Sinopharm Holdings (01099) announced that Sinopharm Group Pharmaceutical Co., Ltd. (600511.SH)), a subsidiary of the company, obtained operating income of RMB 26.728 billion (same unit) in the first half of 2026, an increase of 4.27%; net profit attributable to shareholders of listed companies was RMB 880 million, a decrease of 7.25% year on year; basic earnings per share were 1.1660 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.